176 related articles for article (PubMed ID: 24405551)
1. Characterization of T cell phenotype and function in a double transgenic (collagen-specific TCR/HLA-DR1) humanized model of arthritis.
Tang B; Kim S; Hammond S; Cullins DL; Brand DD; Rosloniec EF; Stuart JM; Postlethwaite AE; Kang AH; Myers LK
Arthritis Res Ther; 2014 Jan; 16(1):R7. PubMed ID: 24405551
[TBL] [Abstract][Full Text] [Related]
2. Characterization of inhibitory T cells induced by an analog of type II collagen in an HLA-DR1 humanized mouse model of autoimmune arthritis.
Kimata M; Cullins DL; Brown ML; Brand DD; Rosloniec EF; Myers LK; Stuart JM; Kang AH
Arthritis Res Ther; 2012 May; 14(3):R107. PubMed ID: 22569209
[TBL] [Abstract][Full Text] [Related]
3. CD8
Whittington KB; Prislovsky A; Beaty J; Albritton L; Radic M; Rosloniec EF
J Immunol; 2022 Jan; 208(1):16-26. PubMed ID: 34819392
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo characterization of the autoimmune T cell response in the HLA-DR1 mouse model of collagen-induced arthritis reveals long-term activation of type II collagen-specific cells and their presence in arthritic joints.
Latham KA; Whittington KB; Zhou R; Qian Z; Rosloniec EF
J Immunol; 2005 Apr; 174(7):3978-85. PubMed ID: 15778354
[TBL] [Abstract][Full Text] [Related]
5. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen.
Rosloniec EF; Brand DD; Myers LK; Whittington KB; Gumanovskaya M; Zaller DM; Woods A; Altmann DM; Stuart JM; Kang AH
J Exp Med; 1997 Mar; 185(6):1113-22. PubMed ID: 9091584
[TBL] [Abstract][Full Text] [Related]
6. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401).
Rosloniec EF; Whittington KB; He X; Stuart JM; Kang AH
Am J Med Sci; 2004 Apr; 327(4):169-79. PubMed ID: 15084912
[TBL] [Abstract][Full Text] [Related]
7. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.
Myers LK; Sakurai Y; Tang B; He X; Rosloniec EF; Stuart JM; Kang AH
Arthritis Rheum; 2002 Dec; 46(12):3369-77. PubMed ID: 12483744
[TBL] [Abstract][Full Text] [Related]
8. Detection of early changes in autoimmune T cell phenotype and function following intravenous administration of type II collagen in a TCR-transgenic model.
Brand DD; Myers LK; Whittington KB; Latham KA; Stuart JM; Kang AH; Rosloniec EF
J Immunol; 2002 Jan; 168(1):490-8. PubMed ID: 11751997
[TBL] [Abstract][Full Text] [Related]
9. Engineered regulatory T cells coexpressing MHC class II:peptide complexes are efficient inhibitors of autoimmune T cell function and prevent the development of autoimmune arthritis.
Qian Z; Latham KA; Whittington KB; Miller DC; Brand DD; Rosloniec EF
J Immunol; 2013 Jun; 190(11):5382-91. PubMed ID: 23630354
[TBL] [Abstract][Full Text] [Related]
10. Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.
Sakurai Y; Brand DD; Tang B; Rosloniec EF; Stuart JM; Kang AH; Myers LK
Arthritis Res Ther; 2006; 8(5):R150. PubMed ID: 16982003
[TBL] [Abstract][Full Text] [Related]
11. An autoantigen-specific, highly restricted T cell repertoire infiltrates the arthritic joints of mice in an HLA-DR1 humanized mouse model of autoimmune arthritis.
Qian Z; Latham KA; Whittington KB; Miller DC; Brand DD; Rosloniec EF
J Immunol; 2010 Jul; 185(1):110-8. PubMed ID: 20511555
[TBL] [Abstract][Full Text] [Related]
12. Visualization and phenotyping of proinflammatory antigen-specific T cells during collagen-induced arthritis in a mouse with a fixed collagen type II-specific transgenic T-cell receptor β-chain.
Merky P; Batsalova T; Bockermann R; Dzhambazov B; Sehnert B; Burkhardt H; Bäcklund J
Arthritis Res Ther; 2010; 12(4):R155. PubMed ID: 20682070
[TBL] [Abstract][Full Text] [Related]
13. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen.
Rosloniec EF; Brand DD; Myers LK; Esaki Y; Whittington KB; Zaller DM; Woods A; Stuart JM; Kang AH
J Immunol; 1998 Mar; 160(6):2573-8. PubMed ID: 9510154
[TBL] [Abstract][Full Text] [Related]
14. The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model.
von Delwig A; Altmann DM; Isaacs JD; Harding CV; Holmdahl R; McKie N; Robinson JH
Arthritis Rheum; 2006 Feb; 54(2):482-91. PubMed ID: 16447222
[TBL] [Abstract][Full Text] [Related]
15. T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage.
He X; Rosloniec EF; Myers LK; McColgan WL; Gumanovskaya M; Kang AH; Stuart JM
Arthritis Rheum; 2004 Jun; 50(6):1996-2004. PubMed ID: 15188377
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of modified recombinant type II collagen in modulating autoimmune arthritis.
Myers LK; Tang B; Brand DD; Rosloniec EF; Stuart JM; Kang AH
Arthritis Rheum; 2004 Sep; 50(9):3004-11. PubMed ID: 15457470
[TBL] [Abstract][Full Text] [Related]
18. Immunization with TCR Vbeta10 peptide reduces the frequency of type-II collagen-specific Th1 type T cells in BUB/BnJ (H-2q) mice.
Anthony DD; Heeger PS; Haqqi TM
Clin Exp Rheumatol; 2001; 19(4):385-94. PubMed ID: 11491493
[TBL] [Abstract][Full Text] [Related]
19. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
Rosloniec EF; Whittington KB; Zaller DM; Kang AH
J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis.
Myers LK; Tang B; Rosloniec EF; Stuart JM; Chiang TM; Kang AH
J Immunol; 1998 Oct; 161(7):3589-95. PubMed ID: 9759881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
